Press releases

Advanced Search
  • Jul 27, 2021

    The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.83 per common share, payable on September 30, 2021 to holders of record on...

  • Jul 27, 2021

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Tepha, Inc., a leading developer and manufacturer of a proprietary...

  • Jul 19, 2021
    BD, Heart to Heart International and the NAFC Announce 2020/2021 Grantees for Multi-YearDiagnostic Testing Initiative to Improve Patient Outcomes

    Alexandria, VA, July 19, 2021 (GLOBE NEWSWIRE) -- As part of a continued effort to support and improve evidence-based care in free and charitable clinics, BD (Becton, Dickinson and Company) (NYSE:...

  • Jul 12, 2021
    David F. Melcher to be non-executive chair; Claire Pomeroy, MD, MBA, to be a director

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that David F. Melcher will be non-executive chair of the board of directors, and Claire...

  • Jul 7, 2021
    New online portal effectively aggregates, customizes and streamlines purchasing of essential reagents to accelerate bold research and clinical innovation

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial release of a new bdbiosciences.com web and eCommerce site, an entirely...

Show 5102550100 per page